It’s been a toasty week in New York. But hey, that’s late July for ya. Hopefully everyone has the beach or pool on their agenda this weekend as temps creep into the 90s. That’s exactly where you can find me on my day off tomorrow!
But first … Just in: Permira has snapped up a majority stake in U.K. pharma services provider Quotient Sciences, providing an exit for GHO Capital. The deal reportedly commanded a valuation of 600 million pounds ($745 million).
Elsewhere, I’ve been busy digging into what some might characterize as next-generation, physician-centric healthcare companies looking to support the industry’s adoption of pay-for-performance, from the traditional fee-for-service model.
One of those companies is CD&R’s Agilon Health, which I’ve learned tapped banks earlier this year to consider an IPO. At the same time, Oak HC/FT-backed VillageMD is seeking $150 million in additional funding, I’m told.
Agilon and VillageMD are among a host of companies which, in their own ways, are looking to take part in changing the way healthcare is delivered and funded.
Amid a massive consolidation of physicians, doctors are demanding resources to succeed in an evolving healthcare ecosystem. That is, one in which performance-based reimbursement arrangements are increasingly encouraged.